Liver Health
Reaching New Heights in Liver Care: The Power of Strategic Advocacy in Liver Health
"The view from the top is always better with the people who helped us get there."
How can pharma build genuine partnerships with patient communities?
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...
Novo Nordisk reports phase 3 data showing semaglutide reduces liver scarring
Patients with MASH in the ESSENCE phase 3 trial show semaglutide’s potential to improve liver health
Stories of sickness: applying illness narratives to health advertising
By Dr Stephanie Goley Introduction As advertisers, we know that health and pharmaceutical campaigns hold enormous influence over how the public perceives illness, wellness, and treatment. But too often, our...
Roche to acquire 89bio in a deal worth up to US$3.5bn
With the agreement, Roche will gain a treatment for moderate to severe MASH
Madrigal’s liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis
The drug has already been approved in the US to treat patients with non-cirrhotic MASH
Eli Lilly and OliX partner to advance early-stage metabolic disease candidate
Metabolic-associated steatohepatitis is expected to affect over 19 million adults in the US by 2039
Novo Nordisk’s GLP-1 drug semaglutide shows promise in fatty liver disease MASH
The company expects to file for regulatory approvals of the drug in this indication next year
Ten ways to start (or continue) your patient engagement journey
Here are 10 easy approaches Pharma teams can take when starting (or continuing) their patient engagement journey!
Expanding Opportunities for Healthcare with “Digital Twins”
Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Realizing the Potential of Genomics-Driven Precision Medicine
Jennifer Helfer, Senior Director, Patient Advocacy & Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials,...